| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Structure Therapeutics Inc. | CHIEF FINANCIAL OFFICER | American Depositary Shares | 2.12K | $64.6K | $30.54 | Nov 20, 2024 | Direct |
| Structure Therapeutics Inc. | CHIEF FINANCIAL OFFICER | Ordinary Shares | 1.55M | Mar 15, 2025 | Indirect | ||
| Structure Therapeutics Inc. | CHIEF FINANCIAL OFFICER | Ordinary Shares | 1.29M | Mar 15, 2025 | Direct | ||
| Structure Therapeutics Inc. | CHIEF FINANCIAL OFFICER | Employee Stock Option (right to buy) | 413K | Mar 15, 2025 | Direct | ||
| Structure Therapeutics Inc. | CHIEF FINANCIAL OFFICER | Stock Option (right to buy) | 148K | Mar 15, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GPCR | Structure Therapeutics Inc. | Mar 15, 2025 | 4 | $0 | 4 | Mar 18, 2025 | CHIEF FINANCIAL OFFICER |
| GPCR | Structure Therapeutics Inc. | Mar 15, 2024 | 1 | $0 | 4/A | Mar 20, 2024 | CHIEF FINANCIAL OFFICER |
| GPCR | Structure Therapeutics Inc. | Mar 15, 2024 | 2 | $0 | 4 | Mar 19, 2024 | CHIEF FINANCIAL OFFICER |
| GPCR | Structure Therapeutics Inc. | Feb 7, 2023 | 1 | $9K | 4 | Feb 9, 2023 | Chief Financial Officer |
| GPCR | Structure Therapeutics Inc. | Feb 2, 2023 | 1 | $0 | 4 | Feb 6, 2023 | Chief Financial Officer |
| GPCR | Structure Therapeutics Inc. | Feb 2, 2023 | 0 | $0 | 3 | Feb 2, 2023 | Chief Financial Officer |